company background image
CODX

Co-Diagnostics NasdaqCM:CODX Stock Report

Last Price

US$3.32

Market Cap

US$102.6m

7D

-2.4%

1Y

-65.3%

Updated

27 Nov, 2022

Data

Company Financials +
CODX fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance1/6
Financial Health6/6
Dividends0/6

CODX Stock Overview

Co-Diagnostics, Inc., a molecular diagnostics company, develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally.

Co-Diagnostics, Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Co-Diagnostics
Historical stock prices
Current Share PriceUS$3.32
52 Week HighUS$10.90
52 Week LowUS$2.76
Beta-0.61
1 Month Change-0.60%
3 Month Change-5.68%
1 Year Change-65.27%
3 Year Change272.99%
5 Year Change-35.41%
Change since IPO-42.86%

Recent News & Updates

Recent updates

Estimating The Intrinsic Value Of Co-Diagnostics, Inc. (NASDAQ:CODX)

Jul 06
Estimating The Intrinsic Value Of Co-Diagnostics, Inc. (NASDAQ:CODX)

Co-Diagnostics, Inc. (NASDAQ:CODX) Shares Could Be 29% Below Their Intrinsic Value Estimate

Mar 28
Co-Diagnostics, Inc. (NASDAQ:CODX) Shares Could Be 29% Below Their Intrinsic Value Estimate

Does Co-Diagnostics (NASDAQ:CODX) Deserve A Spot On Your Watchlist?

Dec 28
Does Co-Diagnostics (NASDAQ:CODX) Deserve A Spot On Your Watchlist?

Co-Diagnostics, Inc.'s (NASDAQ:CODX) Share Price Boosted 42% But Its Business Prospects Need A Lift Too

Aug 14
Co-Diagnostics, Inc.'s (NASDAQ:CODX) Share Price Boosted 42% But Its Business Prospects Need A Lift Too

This Just In: Analysts Are Boosting Their Co-Diagnostics, Inc. (NASDAQ:CODX) Outlook for This Year

May 18
This Just In: Analysts Are Boosting Their Co-Diagnostics, Inc. (NASDAQ:CODX) Outlook for This Year

These Analysts Just Made A Huge Downgrade To Their Co-Diagnostics, Inc. (NASDAQ:CODX) EPS Forecasts

Mar 30
These Analysts Just Made A Huge Downgrade To Their Co-Diagnostics, Inc. (NASDAQ:CODX) EPS Forecasts

US$22.33: That's What Analysts Think Co-Diagnostics, Inc. (NASDAQ:CODX) Is Worth After Its Latest Results

Mar 27
US$22.33: That's What Analysts Think Co-Diagnostics, Inc. (NASDAQ:CODX) Is Worth After Its Latest Results

Things Look Grim For Co-Diagnostics, Inc. (NASDAQ:CODX) After Today's Downgrade

Mar 14
Things Look Grim For Co-Diagnostics, Inc. (NASDAQ:CODX) After Today's Downgrade

Does Co-Diagnostics (NASDAQ:CODX) Have The DNA Of A Multi-Bagger?

Mar 13
Does Co-Diagnostics (NASDAQ:CODX) Have The DNA Of A Multi-Bagger?

Co-Diagnostics, Inc. (NASDAQ:CODX) Shares Could Be 40% Below Their Intrinsic Value Estimate

Feb 15
Co-Diagnostics, Inc. (NASDAQ:CODX) Shares Could Be 40% Below Their Intrinsic Value Estimate

Co-Diagnostics, Inc.'s (NASDAQ:CODX) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?

Jan 25
Co-Diagnostics, Inc.'s (NASDAQ:CODX) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?

Shareholders Are Raving About How The Co-Diagnostics (NASDAQ:CODX) Share Price Increased 994%

Dec 30
Shareholders Are Raving About How The Co-Diagnostics (NASDAQ:CODX) Share Price Increased 994%

Shareholder Returns

CODXUS Medical EquipmentUS Market
7D-2.4%1.9%1.3%
1Y-65.3%-20.2%-18.5%

Return vs Industry: CODX underperformed the US Medical Equipment industry which returned -20.2% over the past year.

Return vs Market: CODX underperformed the US Market which returned -18.5% over the past year.

Price Volatility

Is CODX's price volatile compared to industry and market?
CODX volatility
CODX Average Weekly Movement7.5%
Medical Equipment Industry Average Movement8.6%
Market Average Movement7.4%
10% most volatile stocks in US Market15.6%
10% least volatile stocks in US Market3.3%

Stable Share Price: CODX is not significantly more volatile than the rest of US stocks over the past 3 months, typically moving +/- 8% a week.

Volatility Over Time: CODX's weekly volatility (8%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
2013101Dwight Eganhttps://www.codiagnostics.com

Co-Diagnostics, Inc., a molecular diagnostics company, develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. It offers polymerase chain reaction (PCR) diagnostic tests for COVID-19, tuberculosis, hepatitis B and C, human papilloma virus, malaria, chikungunya, dengue, and the zika virus; three multiplexed tests to test mosquitos for the identification of diseases carried by the mosquitos; and molecular tools for detection of infectious diseases, liquid biopsy for cancer screening, and agricultural applications. The company also provides tests that identify genetic traits in plant and animal genomes; and portable PCR device designed to bring PCR to patients in point-of-care and at-home settings.

Co-Diagnostics, Inc. Fundamentals Summary

How do Co-Diagnostics's earnings and revenue compare to its market cap?
CODX fundamental statistics
Market CapUS$102.65m
Earnings (TTM)US$15.17m
Revenue (TTM)US$53.22m

6.8x

P/E Ratio

1.9x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
CODX income statement (TTM)
RevenueUS$53.22m
Cost of RevenueUS$7.45m
Gross ProfitUS$45.77m
Other ExpensesUS$30.60m
EarningsUS$15.17m

Last Reported Earnings

Sep 30, 2022

Next Earnings Date

n/a

Earnings per share (EPS)0.49
Gross Margin86.00%
Net Profit Margin28.50%
Debt/Equity Ratio0%

How did CODX perform over the long term?

See historical performance and comparison